Clinical/preclinical Consortium


APTrans is a consortium of three drug development companies, all based at Alderley Park, who offer a wide spectrum of skills and experience needed for the smooth running of drug development programmes. The proximity of the three companies facilitates a quick response to any issues should they arise.

In addition to Aptus Clinical, which specialises in the clinical aspects of drug development, APTrans includes:


  • Team of world-renowned nonclinical safety experts
  • Ion channel screening
  • Target safety assessments
  • Drug project toxicology

SEDA Pharmaceutical Development Services

  • Integrated pharmaceutical development and clinical pharmacology service
  • Chemistry manufacturing and controls
  • Formulation strategy
  • Drug delivery system scouting
  • Clinical pharmacology and biopharmaceutics